APA (7th ed.) Citation

C, P., K, N., J, V., B, B., ZH, R., E, M., . . . QV, W. (2024). Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. BMC cancer, 24(1), 1406. https://doi.org/10.1186/s12885-024-13051-6

Chicago Style (17th ed.) Citation

C, Pan, et al. "Development of a Prognostic Signature for Overall Survival Using Peripheral Blood Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors." BMC Cancer 24, no. 1 (2024): 1406. https://doi.org/10.1186/s12885-024-13051-6.

MLA (9th ed.) Citation

C, Pan, et al. "Development of a Prognostic Signature for Overall Survival Using Peripheral Blood Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors." BMC Cancer, vol. 24, no. 1, 2024, p. 1406, https://doi.org/10.1186/s12885-024-13051-6.